Category : Search result: therapy approaches


J&J buys Halda Therapeutics for $3.05 billion

Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.

Moncton Vet Battles for Alternative PTSD Treatments

Retired Master Cpl. Gordon Hurley, a special forces vet in Moncton, reveals his long-hidden PTSD struggle and his fight for access to alternative therapies. His story highlights the urgent need for veteran mental health support.

FDA Approves First CRISPR Gene Therapy

Discover how the FDA's landmark approval of Casgevy, the first CRISPR-based treatment, is transforming genetic medicine and offering hope for sickle cell patients.

Page 2 of 2